scispace - formally typeset
M

Mehmet Toner

Researcher at Harvard University

Publications -  572
Citations -  60830

Mehmet Toner is an academic researcher from Harvard University. The author has contributed to research in topics: Circulating tumor cell & Cancer. The author has an hindex of 113, co-authored 550 publications receiving 54827 citations. Previous affiliations of Mehmet Toner include University of New Mexico & University of Notre Dame.

Papers
More filters
Journal ArticleDOI

Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor

TL;DR: Investigation of the viability and synthetic function of rat hepatocytes cocultured with 3T3-J2 fibroblasts in a small-scale microchannel flat-plate bioreactor with and without an internal membrane oxygenator under flow showed that theBioreactor without the oxygenator resulted in significantly decreased viability and function of hepatocytes, whereas hepatocytes in the bioreactors with internal membranes oxygenator were able to maintain their viability andfunction.
Journal ArticleDOI

The promise of organ and tissue preservation to transform medicine

TL;DR: Developments indicate that a new paradigm, integrating multiple existing preservation approaches and new technologies that have flourished in the past 10 years, could transform preservation research.
Journal ArticleDOI

Advancing the speed, sensitivity and accuracy of biomolecular detection using multi-length-scale engineering

TL;DR: Recent strategies that combine nano- and microscale materials and devices to produce large improvements in detection sensitivity, speed and accuracy, allowing previously undetectable biomarkers to be identified in clinical samples are reviewed.
Journal ArticleDOI

HER2 expression identifies dynamic functional states within circulating breast cancer cells

TL;DR: Combined treatment with paclitaxel and Notch inhibitors achieves sustained suppression of tumorigenesis in orthotopic circulating tumour cell-derived tumour models and points to distinct yet interconverting phenotypes within patient-derived circulating tumours, contributing to progression of breast cancer and acquisition of drug resistance.